Boehringer Ingelheim Pharmaceuticals, Inc. recalls
1 recall filed under Boehringer Ingelheim Pharmaceuticals, Inc.. The most recent was published July 8, 2026.
-
Class II · 4 months ago
Boehringer Ingelheim Pharmaceuticals, Inc. Synjardy XR Tablets , 12.5/1000 mg recall: CGMP Deviations: An incorrect detergent was used and the required swab
CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been…
About this page
Boehringer Ingelheim Pharmaceuticals, Inc. appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.